Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$1byr Graphic](https://lunarcrush.com/gi/w:26/t:$1byr.png) $1byr

Cryptocurrency $1byr sees increased community engagement. Market analysis suggests a period of consolidation is likely ahead.

### About $1byr
A cryptocurrency.  

### Engagements: XX [#](/topic/$1byr/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$1byr/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$1byr/time-series/interactions.tsv)  
**Current Value**: XX  
**Daily Average**: XXX  
**1 Week**: XXX -XX%  
**1 Month**: XXX -XX%  
**1-Year High**: XXXXXX on 2025-07-20  
**1-Year Low**: X on 2025-04-30  

| Social Network | X  |
| -------------- | -  |
| Engagements    | XX |
  

  
  
### Mentions: X [#](/topic/$1byr/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$1byr/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$1byr/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1-Year High**: X on 2025-07-26  
**1-Year Low**: X on 2025-04-29  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$1byr/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$1byr/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$1byr/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $1byr in the last XX hours which is no change from in the previous XX hours
**Daily Average**: X  
**1-Year High**: X on 2025-07-26  
**1-Year Low**: X on 2025-04-29  

**Top topics mentioned**
In the posts about $1byr in the last XX hours

[honour](/topic/honour), [$crvs](/topic/$crvs), [$225myr](/topic/$225myr)

### Top Social Posts [#](/topic/$1byr/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"@A_May_MD @ShortsellerST @seedy19tron I would comment regarding the other indications for $CRVS Soquelitinib for accuracy outside of AD are closer to market should trials succeed. X. Ph3 in PTCL about $1B+/yr sales X. Ph2 in ALPS possible to get FDA approval w/o Ph3 due to rare disease and risks $225M/yr sales"  
[X Link](https://x.com/HOThomasWPhelps/status/1975663840365773112) [@HOThomasWPhelps](/creator/x/HOThomasWPhelps) 2025-10-07T20:45Z 1616 followers, 1255 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$1byr Graphic $1byr

Cryptocurrency $1byr sees increased community engagement. Market analysis suggests a period of consolidation is likely ahead.

About $1byr

A cryptocurrency.

Engagements: XX #


Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Week: XXX -XX%
1 Month: XXX -XX%
1-Year High: XXXXXX on 2025-07-20
1-Year Low: X on 2025-04-30

Social Network X
Engagements XX

Mentions: X #


Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1-Year High: X on 2025-07-26
1-Year Low: X on 2025-04-29

Social Network X
Mentions X

Creators: X #


Creators Line Chart
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $1byr in the last XX hours which is no change from in the previous XX hours Daily Average: X
1-Year High: X on 2025-07-26
1-Year Low: X on 2025-04-29

Top topics mentioned In the posts about $1byr in the last XX hours

honour, $crvs, $225myr

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"@A_May_MD @ShortsellerST @seedy19tron I would comment regarding the other indications for $CRVS Soquelitinib for accuracy outside of AD are closer to market should trials succeed. X. Ph3 in PTCL about $1B+/yr sales X. Ph2 in ALPS possible to get FDA approval w/o Ph3 due to rare disease and risks $225M/yr sales"
X Link @HOThomasWPhelps 2025-10-07T20:45Z 1616 followers, 1255 engagements

$1byr
/topic/$1byr